Open AccessPredictors and rates of treatment-resistant tumor growth in acromegaly
Author(s) -
G. M. Besser,
Pia Burman,
Adrian Daly
Publication year - 2005
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje.1.01968
Subject(s) - acromegaly , medicine , pegvisomant , somatostatin , pituitary tumors , magnetic resonance imaging , radiation therapy , tumor progression , endocrinology , cancer , oncology , hormone , growth hormone , radiology
Multimodal therapy for acromegaly affords adequate disease control for many patients; however, there remains a subset of individuals that exhibit treatment-resistant disease. The issue of treatment-resistant pituitary tumor growth remains relatively under-explored.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom